Detection method: allelic discrimination
This in vitro diagnostic kit is intended for detection of mutations rs429358 and rs7412 in the gene for APOE in human genomic DNA. It enables determination of e2 (cys112, cys158), e3 (cys112, arg158) and e4 (arg112, arg158) genotypes. Examination process is based on a principle of real-time PCR with the use of fluorescently labelled probes (allelic discrimination).
Apolipoprotein E is an important structural component of particles transporting cholesterol (VLDL, HDL) and is a ligand of cell receptors found mainly in the brain and the liver. The apolipoprotein E gene occurs in three forms of alleles, e2, e3 and e4, which code for protein isoforms E2, E3 and E4 respectively. These isoforms characteristically have amino-acids
at positions 112 and 158.
Isoform E3, coded by the e3 allele, is predominantly present in the population (wild-type), and carries cysteine and arginine amino-acids at positions 112 and 158 respectively. There are three homozygous (e2/e2, e3/e3 and e4/e4) and three heterozygous (e2/e3, e3/e4, e2/e4) genotypes present in the population. The e2 allele is associated with the occurrence of type III hyperlipoproteinemia. Isoform E2, coded by this allele, has significantly lower affinition to lipoprotein receptors, compared to isoforms E3 and E4. Individuals carrying this isoform suffer from higher level of triacylglycerols in their plasma. The E4 allele increases LDL cholesterol level and thus is a risk factor of atherosclerosis. In its homozygous form this allele is also connected with the development of the idiopathic form of Alzheimer’s disease. E2 allele is related to a lower risk of occurrence of this disease.
| Cat. No. | Product | No. of reactions | Price |
|---|
| 3206-025 | gb GENETIC APOE | 25 |
Add to Quote Add to Quote |
|
Get this product FREE |
Order for free | ||
1 CE IVD real-time PCR kit contains reagents to provide 25 PCR reactions (20 μl volume of each reaction).
Shiping on dry ice from
€ 110 (EU)
For other destinations see
indicative list.
General Terms and Conditions
Validated for:
ABI 7500/7500 Fast (ABI)
CFX96/96Touch (Bio-Rad)
Light Cycler 480/Cobas z480 (Roche Diagnostics)
QuantStudio 5 (Applied Biosystems)
RG 3000 (Corbett Research)
RG 6000/Q (Corbett Research/Qiagen)
Dual-labeled hydrolysis probes The technology of dual-labeled hydrolysis probes (also called TaqMan® real-time PCR probes) exploits the 5 ́-3 ́ exonuclease activity of Taq DNA polymerase to cleave the probe. TaqMan real-time PCR probes are labeled with a fluorescent dye (reporter) at the 5´ end and with a quencher at the 3´ end.
Lecanemab belongs to the antibody-based treatment approach as might be easily derived from its name Lecanemab where specifically the mab end cap refers to a monoclonal antibody. Lecanemab is registered commercially as Leqembi® and it has been approved by the FDA (Food and Drug Administration) in an accelerated approval pathway in January 2023 however this status changed in the summer of this year when the FDA converted the Leqembi® to traditional approval [1], [2].
Your request has been sent.
Dispatch date
Products are dispatched within 10 business days upon receiving the order
Shipping
On ice/dry ice
Recommended storage
Storage at -20 °C
Expiry date
Product remains stable until expiry date stated on the product label (min. 6 months after delivery)
This product has not been validated for your cycler?
Send us the type of your cycler and we will find a solution for you.
Your request has been sent.
Thank you for your interest in our testing services. We will reply to your e-mail address as soon as possible.
Thank you for your inquiry
Thank you for your inquiry
Your registration has been sent.
Thank you for your inquiry
Price will be calculated based on your exact location within 2 working days.
ENG 
CZE 